Novartis Wins Herpes Drug Patent Fight Against Teva

Law360, New York (November 19, 2009, 6:23 PM EST) -- A jury has sided with Novartis AG in a suit it filed claiming Teva Pharmaceuticals USA Inc. infringed the patent for its genital herpes drug Famvir by seeking regulatory approval to market its own generic version.

The jury in the U.S. District Court for the District of New Jersey found in favor of Novartis and against Teva on Wednesday.

According to Cravath Swaine & Moore LLP, which represented Novartis in this matter along with Fitzpatrick, Cella, Harper & Scinto, Teva had already conceded infringement but claimed...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.